AppliGel (Future Indication)

About Royer Biomedical

Royer Biomedical is a private, US-based company founded in 1995, specializing in advanced polymer-based drug delivery systems. Its core technologies include synthetic hydrogel (AppliGel/VetriGel) and calcium-based (Matrix III) platforms designed for localized, sustained release of therapeutics to enhance efficacy and reduce systemic toxicity. The company has an active clinical program for a gentamicin-loaded gel for diabetic foot ulcers and is advancing veterinary applications, positioning itself at the intersection of novel drug delivery and targeted therapy.

Therapeutic Areas